Global mAb Biosimilars Market Trends 2016-2020

1
Global mAb Biosimilars Market 2016-2020
2
Report Description
Big Market Research provides new report package
Global mAb Biosimilars Market- Size, Share,
Trends, Forecast, Growth, Opportunities
2020   About Biosimilars   Biosimilars or
follow-on biologics are generic versions of the
biopharmaceutical products. These are developed
following the patent expiry of an original
molecule. Biosimilars have the same biological
properties as original drugs and target the same
diseases. They have many similarities but are not
identical to the reference biopharmaceutical
product.   The global monoclonal antibody (mAb)
biosimilars market to grow at a CAGR of 4-7
during the period 2015-2020.   Get Sample Copy of
report _at_ http//www.bigmarketresearch.com/request-
sample/695240  
3
Report Description
Covered in this report The report covers the
present scenario and the growth prospects of the
global monoclonal antibody (mAb) biosimilars
market 2016-2020. To calculate the market size,
the report considers the report considers the
revenue generated from the sales of mAbs. The
report also considers the revenues generated from
the sales of drugs that are expected to be
launched during the forecast period.   The market
is divided into the following segments based on
geography Europe Asia ROW   Global
Monoclonal Antibody (mAb) Biosimilars Market
2016-2020, has been prepared based on an in-depth
market analysis with inputs from industry
experts. The report covers the market landscape
and its growth prospects over the coming years.
The report also includes a discussion of the key
vendors operating in this market.   Purchase
this report for the price of Single User US
2500 http//www.bigmarketresearch.com/checkout-6
95240
4
Report Description
Key vendors Biocon Celltrion Dr. Reddy's
Laboratories Hospira Other prominent vendors
3SBio Accord Healthcare AET Biotech
Allergan Alvartis Pharma Amega Biotech
Amgen Apotex Aspen AstraZeneca Aurobindo
Pharma Baxter Bharat Serums Bio Sidus
Biogen
5
Report Description
Bionovis Bioton BioXpress Therapeutics
Boehringer Ingelheim Boston Oncology Cipla
Coherus Biosciences Daiichi Sankyo Emcure
Pharmaceuticals Gedeon Richter GeneScience
Pharmaceuticals GSK Hetero Drugs iBio
Intas Pharmaceuticals JCR Pharmaceuticals LG
Lifesciences Lonza Merck Mitsubishi Tanabe
Pharma Momenta Pharmaceuticals
6
Report Description
Mylan Natco Pharma Novartis Pfenex
Pfizer Ranbaxy Laboratories Roche Holding
Samsung Biologics Sanofi Synthon   Market
driver Rise in number of patent expiries For
a full, detailed list, view our report Market
challenge Physicians' reluctance to prescribe
biosimilars For a full, detailed list, view our
report  
7
Report Description
Market trend Emergence of biosimilars For a
full, detailed list, view our report   Key
questions answered in this report What will
the market size be in 2020 and what will the
growth rate be? What are the key market
trends? What is driving this market? What are
the challenges to market growth? Who are the
key vendors in this market space? What are the
market opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors?  
8
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/global-mab-biosi
milars-2016-2020-market
Stay With Us
TELEPHONE [phone] EMAIL
help_at_bigmarketresearch.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States